publication venue for

• Longitudinal plasma kallikrein levels and their association with the risk of cardiovascular disease outcomes in type 1 diabetes in DCCT/EDIC 2020
• Longitudinal plasma kallikrein levels and their association with the risk of cardiovascular disease outcomes in type 1 diabetes in DCCT/EDIC 2020
• Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study 2020
• Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program. 2019
• Immune Complexes and the Risk of CVD in Type 1 Diabetes. 2019
• . Immune complexes and the risk of CVD in type 1 diabetes 2019
• Immune complexes and the risk of CVD in type 1 diabetes 2019
• Risk factors for Cardiovascular Disease in Type 1 Diabetes. 2016
• New locus for skin intrinsic fluorescence in type 1 diabetes also associated with blood and skin glycated proteins 2016
• Risk factors for cardiovascular disease in type 1 diabetes 2016
• Effect of intensive diabetes therapy on the progression of diabetes retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. 2015
• Risk Factors for Cardiovascular Disease in Type 1 Diabetes 2015
• Skin advanced glycation endproducts (AGEs) glucosepane and methyglyoxal hydroimidazolone are independently associated with long-term microvascular complication progress of type 1 diabetes. 2015
• . Factors Affecting the Decline in Incidence of Diabetes in the Diabetes Prevention Program Outcome Study (DPPOS). 2014
• Evaluating the role of epigenetic histone modifications in the Metabolic Memory of Type 1 Diabetes 2014
• Regression from Pre-diabetes to Normal Glucose Regulation is Associated with Reduction in Cardiovascular Risk: Results from the Diabetes Prevention Program Outcomes Study 2014
• Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin 2005
• Are Insulin and Proinsulin Independent Risk Factors for Premature Coronary Artery Disease? 1996
• Human Proinsulin Verses Oral Agent Treatment in NIDDM 1987
• Vitamin B12 Deficiency in the Diabetes Prevention Program Outcome Study (DPPOS) 2013